CN103768561B - 止眩安神片在制备抑制淋巴瘤el4细胞增殖药物中的应用 - Google Patents
止眩安神片在制备抑制淋巴瘤el4细胞增殖药物中的应用 Download PDFInfo
- Publication number
- CN103768561B CN103768561B CN201310669929.9A CN201310669929A CN103768561B CN 103768561 B CN103768561 B CN 103768561B CN 201310669929 A CN201310669929 A CN 201310669929A CN 103768561 B CN103768561 B CN 103768561B
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- dizzy
- ethanol
- mind tranquilizing
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000002173 dizziness Diseases 0.000 title claims abstract description 44
- 230000002936 tranquilizing effect Effects 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 230000004663 cell proliferation Effects 0.000 claims abstract description 12
- 206010025323 Lymphomas Diseases 0.000 claims abstract description 11
- 239000009636 Huang Qi Substances 0.000 claims abstract description 9
- 229940126678 chinese medicines Drugs 0.000 claims abstract description 9
- 210000000582 semen Anatomy 0.000 claims abstract description 9
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 83
- 239000000284 extract Substances 0.000 claims description 22
- 238000000605 extraction Methods 0.000 claims description 21
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 11
- 239000008187 granular material Substances 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 7
- 230000000274 adsorptive effect Effects 0.000 claims description 7
- 230000006837 decompression Effects 0.000 claims description 7
- 239000003480 eluent Substances 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 229920005989 resin Polymers 0.000 claims description 7
- 239000011347 resin Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 abstract description 12
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 abstract description 12
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 abstract description 12
- 229960004756 ethanol Drugs 0.000 description 30
- 238000000034 method Methods 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- QZKDXSOKZHLFHE-UHFFFAOYSA-N 4-(1,3-benzodioxol-5-yl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=C(OCO2)C2=C1 QZKDXSOKZHLFHE-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 238000009923 sugaring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 药物浓度(mg/ml) | 抑制率(%) |
对照组 | 0 | 0 |
1 | 5 | 9.48±8.65 |
2 | 10 | 17.69±10.42* |
3 | 15 | 28.56±12.17** |
4 | 20 | 39.62±16.89** |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310669929.9A CN103768561B (zh) | 2013-12-10 | 2013-12-10 | 止眩安神片在制备抑制淋巴瘤el4细胞增殖药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310669929.9A CN103768561B (zh) | 2013-12-10 | 2013-12-10 | 止眩安神片在制备抑制淋巴瘤el4细胞增殖药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103768561A CN103768561A (zh) | 2014-05-07 |
CN103768561B true CN103768561B (zh) | 2016-03-02 |
Family
ID=50561621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310669929.9A Active CN103768561B (zh) | 2013-12-10 | 2013-12-10 | 止眩安神片在制备抑制淋巴瘤el4细胞增殖药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103768561B (zh) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103386109B (zh) * | 2013-07-27 | 2016-09-07 | 陈有春 | 一种治疗淋巴癌的中药组合物 |
-
2013
- 2013-12-10 CN CN201310669929.9A patent/CN103768561B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103768561A (zh) | 2014-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103690646B (zh) | 一种益康补元片的制备方法及其在抑制小鼠淋巴瘤细胞yac-1细胞增殖药物中的应用 | |
CN103655843B (zh) | 一种益康补元片及其制备方法和应用 | |
CN103638450B (zh) | 一种木香理气片的制备方法及应用 | |
CN103690647B (zh) | 一种益康补元片的制备方法及其在抑制小鼠白血病细胞l6565细胞增殖药物中的应用 | |
CN103800498B (zh) | 一种青梅感冒片的制备方法及其在抑制列腺癌细胞rm-1细胞增殖药物中的应用 | |
CN103768211B (zh) | 一种青梅感冒片的制备方法及其在抑制淋巴瘤细胞el4细胞增殖药物中的应用 | |
CN105535515A (zh) | 绿及咳喘片在制备抑制前列腺癌细胞pc-3细胞增殖药物中的应用 | |
CN103655842B (zh) | 一种益康补元片的制备方法及其在抑制小鼠淋巴瘤细胞el4.il-2细胞增殖药物中的应用 | |
CN103768561B (zh) | 止眩安神片在制备抑制淋巴瘤el4细胞增殖药物中的应用 | |
CN103655841B (zh) | 一种益康补元片的制备方法及其在抑制小鼠淋巴样瘤细胞p388d1细胞增殖药物中的应用 | |
CN103655839B (zh) | 一种益康补元片的制备方法及其在抑制小鼠肺癌细胞llc细胞增殖药物中的应用 | |
CN103751424A (zh) | 一种青梅感冒片的制备方法及其在抑制畸胎瘤细胞f9细胞增殖药物中的应用 | |
CN103768207B (zh) | 一种青梅感冒片的制备方法及其在抑制肝癌细胞Hepa1-6细胞增殖药物中的应用 | |
CN103751350B (zh) | 一种青梅感冒片的制备方法及其在抑制白血病细胞l1210细胞增殖药物中的应用 | |
CN103768266A (zh) | 一种青梅感冒片的制备方法及其在抑制白血病细胞l6565细胞增殖药物中的应用 | |
CN103655838B (zh) | 一种益康补元片的制备方法及其在抑制小鼠淋巴瘤细胞l5178y细胞增殖药物中的应用 | |
CN103655840B (zh) | 一种益康补元片的制备方法及其在抑制小鼠白血病细胞l1210细胞增殖药物中的应用 | |
CN103800871A (zh) | 止眩安神片在制备抑制畸胎瘤细胞f9细胞增殖药物中的应用 | |
CN104288658A (zh) | 一种阿里红咳喘片的制备方法及其在抑制小鼠骨髓瘤细胞sp2/0 细胞增殖药物中的应用 | |
CN103751351B (zh) | 一种青梅感冒片的制备方法及其在抑制睾丸间质细胞瘤细胞mltc-1细胞增殖药物中的应用 | |
CN103768210B (zh) | 一种青梅感冒片的制备方法及其在抑制肛门肉瘤细胞s-180细胞增殖药物中的应用 | |
CN103768209B (zh) | 一种青梅感冒片的制备方法及其在抑制骨髓瘤细胞p3x63ag8细胞增殖药物中的应用 | |
CN103768264A (zh) | 一种青梅感冒片的制备方法及其在抑制畸胎瘤细胞p19细胞增殖药物中的应用 | |
CN103800569A (zh) | 一种青梅感冒片的制备方法及其在抑制淋巴瘤细胞yac-1细胞增殖药物中的应用 | |
CN103768265A (zh) | 一种青梅感冒片的制备方法及其在抑制肺癌细胞llc细胞增殖药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Jin Shuxiang Inventor after: Yu Xirong Inventor after: Sun Weifeng Inventor before: Sun Bo |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160129 Address after: 266011 Shandong province Qingdao City, Pingxiang Road No. 22 atrium Mountain District 6 Building 3 unit 401 Applicant after: Liu Mei Address before: 250001 Shandong Province, Ji'nan City District Court building 2303 No. 288 Applicant before: JINAN XINQIDIAN MEDICAL TECHNOLOGY Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221229 Address after: No. 200 Huihe Road, Wuxi City, Jiangsu Province Patentee after: AFFILIATED HOSPITAL OF JIANGNAN University Address before: 266011 Room 401, unit 3, building 6, Zhongting Shanjing community, 22 Pingxiang Road, Shibei District, Qingdao City, Shandong Province Patentee before: Liu Mei |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230426 Address after: No. 200 Huihe Road, Wuxi City, Jiangsu Province Patentee after: AFFILIATED HOSPITAL OF JIANGNAN University Patentee after: Zhang Bin Address before: No. 200 Huihe Road, Wuxi City, Jiangsu Province Patentee before: AFFILIATED HOSPITAL OF JIANGNAN University |
|
TR01 | Transfer of patent right |